Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury

Clinical and Investigative Medicine

Volumn 35, Issue 6, 2012, Pages

  Korkmaz, Gulcan G ^a   Uzun, Hafize ^b   Cakatay, Ufuk ^b   Aydin, Seval ^b  

^a KIRKLARELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; MALONALDEHYDE; MELATONIN; OXYGEN; STREPTOZOCIN; THIOL DERIVATIVE;

ANIMAL; ARTICLE; BODY WEIGHT; CHEMISTRY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; INJURY; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT; TIME; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLUTATHIONE; HYPERGLYCEMIA; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MELATONIN; OXIDATIVE STRESS; OXYGEN; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; STREPTOZOCIN; SULFHYDRYL COMPOUNDS; TIME FACTORS;

EID: 84872452960     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38.
2. Takasu N, Komiya T, Asawa T, et al. Streptozotocin and alloxan induced H2O2 generation and DNA fragmentation. Diabetes 1991;40:1141-5.
3. Tahan V, Ozaras R, Canbakan B, et al. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res 2004;37:78-84.
4. Hoyos M, Guerrero JM, Perze-Cano R, et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in dietinduced hypercholesterolemic rats. J Pineal Res 2000;28:150-5.
5. Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M, et al. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res. 2009;46:333-7.
6. Gül M, Emre S, Esrefoglu M, et al. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocininduced diabetic rats. Cornea. 2008;27:795-801.
7. Fadillioglu E, Kurcer Z, Parlakpinar H, et al. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res. 2008;31:705-12.
8. Kurcer Z, Parlakpinar H, Vardi N, et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes. 2007;115:365-71.
9. Aksoy N, Vural H, Sabuncu T, et al. effects of melatonin on oxidative-antioxidative status of tissues in streptozotocininduced diabetic rats. Cell Biochem Funct. 2003;21:121-5.
10. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
11. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984;105: 328-31.
12. Hu ML Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994 233:381-85.
13. Beutler E, Duran O, Kelly MB. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-88.
14. Shaker ME, Houssen ME, Abo-Hashem EM, Ibrahim TM. Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress. J Physiol Biochem. 2009;65:225-33.
15. Fadillioglu E, Kurcer Z, Parlakpinar H, Iraz M, Gursul C. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res. 2008;31(6):705-12.
16. Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38.
17. Naudi A, Jove M, Ayala V, Cassanye A, Serrano J, Gonzalo H, Boada J, Prat J, Portero-Otin M, Pamplona R. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp Diabetes Res. 2012;:696215.
18. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44:26-40.
19. Kanter M, Uysal H, Karaca T, et al. Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch Toxicol 2006; 80:362-369.
20. Nishida S, Segawa T, Murai I et al. Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity. J Pineal Res 2002;32:26-33.
21. Montilla PL, Vargas JF, Tunez IF et al. Oxidative stres in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998;25:94-100.
22. Vural H, Sabuncu T, Arslan SO et al. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 2001; 31:193-198.
23. Agil A, Reiter RJ, Jiménez-Aranda A, Ibán-Arias R, Navarro-Alarcón M, Marchal JA, Adem A, Fernández-Vázquez G. Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. J Pineal Res. 2012 Aug 23. [Epub ahead of print].
24. Zavodnik IB, Lapshina EA, Cheshchevik VT, Dremza IK, Kujawa J, Zabrodskaya SV, Reiter RJ. Melatonin and succinate reduce rat liver mitochondrial dysfunction in diabetes. J Physiol Pharmacol. 2011;62:421-7.
25. Srinivasan V, Ohta Y, Espino J, Pariente JA, Rodríguez AB, Mohamed M, Zakariah R. Metabolic Syndrome, Its Pathophysiology and the Role of Melatonin. Recent Pat Endocr Metab Immune Drug Discov. 2012 Aug 29. [Epub ahead of print]
26. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983;52:711-60.
27. Cakatay U, Telci A, Kayali R, et al. Effect of α-lipoic acid supplementation on oxidative protein damage in the streptozotocindiabetic rat. Res Exp Med (Berl). 2000;199:243-51.
28. Baynes JW. Role of oxidative stress in development of complications in diabetes, Diabetes 1991;40:405-412.
29. Attia SM, Helal GK, Alhaider AA. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chem Biol Interact. 2009;180:296-304.
30. Gürpinar T, Ekerbiçer N, Uysal N, Barut T, Tarakçi F, Tuglu MI. The effects of the melatonin treatment on the oxidative stress and apoptosis in diabetic eye and brain. The Scientific World Journal 2012;498:489.
31. do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG, Peres R, Nogueira TC, Afeche SC, Cipolla-Neto J. Early-stage retinal melatonin synthesis impairment in streptozotocininduced diabetic Wistar rats. Invest Ophthalmol Vis Sci. 2011;52:7416-22.
32. Bekyarova G, Apostolova M, Kotzev I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor kappa B activation. Int J Immunopathol Pharmacol. 2012;25(3):591-6.
33. Manikonda PK, Jagota A. Melatonin administration differentially affects age-induced alterations in daily rhythms of lipid peroxidation and antioxidant enzymes in male rat liver. Biogerontology. 2012;13:511-24.
34. Huang HY, Helzlsouer KJ, Appel LJ. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol. Biomarkers Prev. 2000;9:647-52.
35. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011;164:899-904